Center Of Target Therapy
Clinical trials sponsored by Center Of Target Therapy, explained in plain language.
-
New hope for Hard-to-Treat hepatitis c: Two-Drug combo shows promise in early trial
Disease control OngoingThis study is following 30 adults with chronic hepatitis C genotype 3 and mild to moderate liver fibrosis (stages F0-F2) who are taking the antiviral drugs ravidasvir and sofosbuvir as part of their regular care. Researchers want to see how many people have no detectable virus in…
Sponsor: Center of target therapy • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Can a diabetes drug reverse fatty liver? new study aims to find out
Disease control OngoingThis study looks at how well the drug semaglutide works for people with metabolic fatty liver disease (MAFLD) and liver scarring. About 70 adults will take the drug for 3 years as part of their regular care. Researchers will check changes in liver fat, inflammation, and scarring …
Sponsor: Center of target therapy • Aim: Disease control
Last updated May 08, 2026 12:01 UTC